Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Drug-induced AF: Arrhythmogenic Mechanisms and Management Strategies
Drug-induced AF

Review Article

Author(s): Bingxun Li , Mingjie Lin , Lin Wu Added: 2 years ago

Electrophysiology & Arrhythmia
Defining AF Cardiomyopathy
Author(s): Nikhil Ahluwalia , Shohreh Honarbakhsh , Ross Hunter , et al Added: 1 month ago

Electrophysiology & Arrhythmia

Heart Failure
AFSymposium 24: LAA Exclusion in Addition to PVI for Non-paroxysmal AFIB
Author(s): Dhanunjaya Lakkireddy Added: 2 years ago
AFSymposium 2024 — In this interview, investigator, Dr Dhanunjaya Lakkireddy (Kansas City Heart Rhythm Institute, US) shares the key findings from the aMAZE Continued Access Protocol (AtriCure).This study is the extension of the aMAZE Trial investigation in the form of a nested, non-randomised registry. The study looked at the LARIAT System, which percutaneously isolates and ligates the left… View more

Electrophysiology & Arrhythmia
Ventricular Tachycardia After Cardioversion
Author(s): Eiad Habib , Mahmoud Abdelnabi , Ramzi Ibrahim , et al Added: 4 months ago

Electrophysiology & Arrhythmia

Heart Failure
HRS 25: The BIO-LIBRA Study
Author(s): Valentina Kutyifa Added: 11 months ago
HRS 2025 - Contemporary outcomes from implantable devices in non-ischemic cardiomyopathy patients observed more advanced heart failure symptoms in women at the time of ICD implantation, and white women implanted with CRT-D devices had significantly lower ventricular arrhythmia events compared to men of all races and black women implanted with both device types.Dr Valentina Kutyifa (University of… View more

Demographic

Electrophysiology & Arrhythmia
ESC 23: MULTISTARS AMI Trial
Author(s): Linda Joosten Added: 2 years ago
ESC 2023 — Dr Linda Joosten (Julius Center for Health Sciences and Primary Care, NL) joins us to discuss the findings of the FRAIL-AF trial. FRAIL-AF is a multicentre, open-label randomised controlled clinical trial which studied frail elderly patients who receive vitamin K antagonist (VKA) treatment for atrial fibrillation (AF). Current clinical guidelines recommend non-vitamin K antagonists … View more

Anticoagulation

Demographic
EHRA 24: A Substudy of NOAH-AFNET 6
Author(s): Julius Nikorowitsch Added: 1 year ago
EHRA 24 - We are joined onsite by Dr Julius Nikorowitsch (University Heart and Vascular Centre Hamburg (UHZ), DE) to outline the impact of age, sex, cardiovascular comorbidities, and kidney function on outcomes with oral anticoagulation therapy in patients with device-detected atrial fibrillation in a substudy of the NOAH-AFNET 6 trial (NCT02618577).The substudy consisted of 2534 patients from… View more

Electrophysiology & Arrhythmia
Anatomical Determinants of Papillary Muscle Arrhythmias in Apparently Normal Hearts
Author(s): Santiago Rivera , Maria de la Paz Ricapito , Ricardo Ronderos , et al Added: 8 months ago

Electrophysiology & Arrhythmia

Imaging & Diagnostics
Functional Substrate Mapping
Author(s): Jaffar Al-Sheikhli , Patrick Tran , Rafaella Siang , et al Added: 1 year ago

Electrophysiology & Arrhythmia
Latest Advances and Ongoing Challenges in PFA
Author(s): Sara Vázquez-Calvo , Vladimir Poletaev , Atul Verma Added: 1 month ago

Electrophysiology & Arrhythmia